Open AccessRebuttal: PRO Position. Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial
Author(s) -
Dick de Zeeuw,
Hiddo J. Lambers Heerspink
Publication year - 2010
Publication title -
american journal of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 85
eISSN - 1421-9670
pISSN - 0250-8095
DOI - 10.1159/000313562
Subject(s) - medicine , rebuttal , microalbuminuria , clinical endpoint , position (finance) , clinical trial , urology , cardiology , intensive care medicine , renal function , political science , law , finance , economics